Skip to main content
Livermore
Livermore
ZHEN

Fate Therapeutics Inc

FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001434316

In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Fate Therapeutics Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of FATE: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders2331239+7
Shares109.5M60107.8M−1.72M (−1.6%)
Value$2.70B$1.00K$2.41B−$282.2M (−10.5%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Fate Therapeutics Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to FATE in Q3 2022
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC537,519$12.0M0.02%
T. Rowe Price Investment Management, Inc.406,144$9.10M0.01%
Octagon Capital Advisors LP331,096$7.42M1.28%
Baker Bros. Advisors LP215,695$4.83M0.03%
Twinbeech Capital LP213,168$4.78M0.13%
Two Sigma Investments, LP189,067$4.24M0.01%
HRT Financial LP106,125$2.38M0.03%
Moody Aldrich Partners LLC72,304$1.62M0.33%
Engineers Gate Manager LP45,113$1.01M0.06%
Echo Street Capital Management LLC36,358$815.0K0.01%
Moore Capital Management, LP29,993$672.0K0.02%
ExodusPoint Capital Management, LP25,474$571.0K0.01%
L & S Advisors Inc24,946$559.0K0.10%
Qube Research & Technologies Ltd23,090$517.0K0.00%
Dynamic Technology Lab Private Ltd20,820$467.0K0.05%
Seven Eight Capital, LP20,614$462.0K0.09%
XTX Topco Ltd20,520$460.0K0.11%
Man Group plc17,300$388.0K0.00%
Rothschild Investment Corp17,250$387.0K0.04%
Bayesian Capital Management, LP14,836$332.0K0.07%
Campbell & CO Investment Adviser LLC14,432$323.0K0.07%
AlphaCrest Capital Management LLC12,823$287.0K0.02%
Virtu Financial LLC12,673$284.0K0.03%
Glenmede Trust Co NA9,245$207.0K0.00%
Virtus Investment Advisers, Inc.5,137$115.0K0.05%
Kessler Investment Group, LLC3,675$82.0K0.07%
Aquatic Capital Management LLC3,300$74.0K0.01%
Quantbot Technologies LP3,100$69.0K0.01%
China Universal Asset Management Co., Ltd.909$20.0K0.01%
Wipfli Financial Advisors LLC,498$11.0K0.00%
Brown Brothers Harriman & Co79$2.00K0.00%
Massmutual Trust Co FSB60$1.00K0.00%
Capital Advisors, Ltd. LLC7$00.00%

Sold out (26)

Institutions that held Fate Therapeutics Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of FATE in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Ally Bridge Group (NY) LLC181,500$4.50M
Polar Asset Management Partners Inc.170,000$4.21M
Kynam Capital Management, LP81,064$2.01M
Endurant Capital Management LP71,640$1.77M
Osterweis Capital Management Inc41,605$1.03M
Tekla Capital Management LLC31,652$784.0K
Allianz Asset Management GmbH24,918$617.0K
PDT Partners, LLC20,683$513.0K
Squarepoint Ops LLC13,207$327.0K
SG Americas Securities, LLC13,076$324.0K
Magnetar Financial LLC12,831$318.0K
JustInvest LLC10,100$250.0K
Beacon Pointe Advisors, LLC9,100$226.0K
Quantamental Technologies LLC8,526$211.0K
Wilshire Advisors LLC4,083$101.0K
Compagnie Lombard Odier SCmA1,800$45.0K
STRS Ohio500$12.0K
Captrust Financial Advisors474$12.0K
Asset Management One Co.,Ltd.300$7.00K
Prospera Financial Services Inc75$2.00K
Ellevest, Inc.21$1.00K
Central Trust Co4$0
Umb Bank N A6$0
Northwestern Mutual Wealth Management Co2$0
First Horizon Advisors, Inc.8$0
Concord Wealth Partners19$0

Not filed for Q3 2022 yet (1)

Institutions that held Fate Therapeutics Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FATE in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Brewin Dolphin Ltd60$1.00K